USA – FDA Approves First Generic Versions of EpiPen

The US Food and Drug Administration on Thursday approved Teva Pharmaceuticals’ first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis) in adults and children weighing more than 33 pounds.

The approval comes as the US has grappled with shortages of EpiPens and following delays. The approval means Teva can market its generic, substitutable epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.

Teva said in a statment: « We’re applying our full resources to this important launch in the coming months and eager to begin supplying the market. »…